Bacterial News and Research

RSS

Research could put penicillin back in battle against antibiotic resistant bugs

Research led by the University of Warwick has uncovered exactly how the bacterium Streptococcus pneumoniae has become resistant to the antibiotic penicillin.

13 Mar 2008

Humble cup of tea inhibits anthrax

A cup of black tea could be the next line of defence in the threat of bio-terrorism according to new international research.

13 Mar 2008

Aerosol vaccine provides low-cost, needle-free TB treatment

A novel aerosol version of the most common tuberculosis (TB) vaccine, administered directly to the lungs as an oral mist, offers significantly better protection against the disease in experimental animals than a comparable dose of the traditional injected vaccine, researchers report this week in the Proceedings of the National Academy of Sciences.

13 Mar 2008

Caspase-12: MUHC researcher finds new defense mechanism against intestinal inflammation

The body's first line of defence against pathogenic bacteria that we ingest may not be the immune system but rather the cells that line the intestine.

13 Mar 2008

Anadis licenses antibody technologies from ImmuCell

Anadis Limited, an Australian-based biotechnology company focused on milk derived polyclonal antibodies and other milk-derived bioactives, announced today that it had signed a final agreement with ImmuCell Corporation, a biotechnology company headquartered in Portland, Maine, USA.

11 Mar 2008

Scientists unlock secrets of E coli contamination

Using new genetic techniques, scientists are unlocking the secrets of how E coli bacteria contaminate food and make people sick.

11 Mar 2008

Hib meningitis eliminated in children under 5 in Uganda

Hib meningitis has been virtually eliminated in young children in Uganda just five years after the country introduced Haemophilus influenzae type b (Hib) vaccine nationwide, according to an independent study.

11 Mar 2008

Tackling antimicrobial resistance

Drug resistance is making many diseases increasingly difficult and sometimes impossible to treat, according to Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

11 Mar 2008

Peptoids as new class of antibiotic drugs

Drug-resistant bacterial infections are a growing concern, and much research has been devoted to finding new classes of antibiotics to fight them.

10 Mar 2008

Bioniche receives fast track for bladder cancer therapy

Bioniche Life Sciences Inc. has announced that it has received notice from the U.S. Food and Drug Administration (FDA) that its therapy for first-line non-muscle-invasive bladder cancer meets the criteria for Fast Track designation.

6 Mar 2008

Biologists discover parochial bacterial viruses

Biologists examining ecosystems similar to those that existed on Earth more than 3 billion years ago have made a surprising discovery: Viruses that infect bacteria are sometimes parochial and unrelated to their counterparts in other regions of the globe.

6 Mar 2008

New research aims to eliminate Streptococcus infections

Professor Howard Jenkinson in the Department of Oral & Dental Science (Dental School) at the University of Bristol has been awarded a grant of £285,000 from The Wellcome Trust to research ways to combat diseases caused by Streptococcus bacteria.

5 Mar 2008

Killing cancer tumors with Salmonella bacteria

Neil Forbes of the University of Massachusetts Amherst has received a four-year grant of more than $1 million from the National Institutes of Health to research killing cancer tumors with Salmonella bacteria.

1 Mar 2008

Customized treatments for sepsis lower treatment time and reduce length of ICU stays

Using a blood test and a decision algorithm, rather than standard hospital protocols, to determine the appropriate length of antibiotic therapy in patients with severe sepsis or septic shock can reduce duration of treatments, shorten ICU stays, and lower hospital costs - all without adverse effects on patients, according to new research.

1 Mar 2008

Potential target to treat deadly bloodstream infections

Researchers at the University of Illinois at Chicago have discovered a possible target to treat bloodstream bacterial infections.

28 Feb 2008

Using microorganisms to remove trichloroethene from water

In 2002, Bruce Rittmann, PhD, director of the Biodesign Institute's Center for Environmental Biotechnology, received a patent for an innovative way to use nature to lend society a hand.

28 Feb 2008

Rain-making bacteria

Brent Christner, LSU professor of biological sciences, in partnership with colleagues in Montana and France, recently found evidence that rain-making bacteria are widely distributed in the atmosphere.

28 Feb 2008

Discovery of potential drug targets for sepsis

"We have identified a key connection of signaling pathways in the cascade of events leading to sepsis. This defines a crucial point where the immune system spirals out of control to cause severe sepsis and where there is an opportunity for therapeutic intervention," says Scripps Research Professor Wolfram Ruf, who led the research with his postdoctoral fellow Frank Niessen.

28 Feb 2008

Scientists look at 'syringe' assembly in plague bacteria

Bacteria that cause the bubonic plague avoid death in our bodies by injecting our cells with immune evasion proteins.

28 Feb 2008

Soil-dwelling bacteria provide potential new antibiotics

MIT biologists have provoked soil-dwelling bacteria into producing a new type of antibiotic by pitting them against another strain of bacteria in a battle for survival.

27 Feb 2008